GA²LEN, the Global Allergy and Asthma European Network (link) was created to combat fragmentation in the European research area, ensuring excellence in EU allergy and asthma research by bringing together institutions and researchers from across the EU. The network notably put in place centralized structures and an office overseeing the multiple assets in knowledge in the different GA²LEN partners, enabling them to optimally synchronize their research efforts.

GA²LEN is now recognized worldwide as the EU’s groundbreaking allergy organization.

GA²LEN’s vision is further reduce the burden of allergic diseases in Europe by improving the health of European Citizens with allergic diseases; increasing the competitiveness and boosting the innovative capacity of EU health-related industries and businesses while addressing health issues including emerging allergies.

To this end GA²LEN has launched a program for the development, interaction and accreditation of centers of reference and excellence in special areas of allergy. These centers are specialized in

Angioedema (ACARE)

Urticaria (UCARE)

Atopic Dermatitis (ADCARE)

Anaphylaxis (ANACARE)

Allergic Rhinitis (ARIACARE)